Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 14, 2012
View Archived Issues
Astellas presents promising in vitro and in vivo results for a novel antifungal agent
Read More
Boehringer Ingelheim presents new PDE9A inhibitors
Read More
Indian researchers disclose novel agents for cancer
Read More
New agents for parasitic infections patented by U.S. team
Read More
SRI-011225 shows favorable toxicology and efficacy profile in vitro
Read More
Synergy Pharmaceuticals files IND for GC-C agonist
Read More
Vascular Pharmaceuticals raises funds to support development of VPI-2690B
Read More
Concert Pharmaceuticals discloses novel deuterated hydroxybutyrate analogues
Read More
New antiviral agents patented by German researchers
Read More
Cancer Therapeutics CRC synthesizes novel agents for cancer
Read More
Amitiza approved in U.K. for chronic idiopathic constipation
Read More
First-in-human results presented for a novel anti-HIV-1 vaccine
Read More
Takeda obtains U.K. license for erectile dysfunction medication
Read More
Kyowa Hakko Kirin to return Busulfex rights
Read More
Xtandi now available in the U.S.
Read More
Zealand Pharma's dual-acting candidate enters phase I trial
Read More
Critical Outcome Technologies and Delmar Chemicals sign R&D collaboration
Read More
PSAP evaluated as a new urinary biomarker for monitoring Fabry's disease
Read More
Primary endpoint met in first stage of phase II Reolysin trial
Read More
First phase finishes in endometrial regenerative cell therapy project
Read More
Phase III study of Androxal enrolls first patients
Read More
FDA approves production of [11C]-choline injection for PET imaging
Read More
Phase II study begins of GBR-500 in ulcerative colitis
Read More
DSMB recommends continuation of Prana's IMAGINE trial
Read More
Pivotal pharmacokinetic study of BEMA-buprenorphine/naloxone meets objectives
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe